Microtransplantation Improves Remission Durability in High-Risk MDS
Stem Cell Microtransplantation: A New Hope for AML and MDS Patients? A recent study presented at the European Society for Blood and Marrow Transplantation (EBMT) 52nd Annual Meeting suggests a promising new approach for patients battling acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (HR-MDS). Combining umbilical cord blood stem cell microtransplantation with standard chemotherapy … Read more